trial · primary record
Maridebart Cafraglutide
Obesity or Overweight
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 300 |
| Primary completion | 2028-02-28 |
| Primary endpoint | Percent Change from Baseline in Body Weight at Week 68 |
| Registry ID | NCT07575399 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:22.619Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07575399
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.